Glixx Laboratories Inc
Your exclusive source for bioactive molecules
Chemical Name: 3-(4-Phenylbutyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol
Purity: >98% (HPLC)
Novel GluN2B-specific NMDAR antagonist, completely preventing the decrease in insulin secretion of about 32 % provoked by a 24-h-treatment with NMDA/glycine, eliminating NMDA-induced changes in the oxidation status of the islet cells and elevating the sensitivity of intracellular calciumto 15 mM glucose
Place an order!